Form 8-K VERTEX PHARMACEUTICALS For: Nov 04
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- BofA Securities Reiterates Buy Rating on Apple (AAPL)
- Paradium AI (PAAI) Halted, News Pending
- Shipping stocks on fire — but cracks are forming in the rate rally
Vertex (VRTX) PT Raised to $451 at RBC Capital
November 5, 2024 7:00 AM ESTRBC Capital analyst Brian Abrahams raised the price target on Vertex (NASDAQ: VRTX) to $451.00 (from $437.00) while maintaining a Sector Perform rating.
The analyst comments "CF beat and raise shows the continued health of the company's core franchise and is likely to perpetuate... More
